Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-17

Clinical Trial Update: Romosozumab Use to Build Skeletal Integrity [Phase 4]

View source ↗

Summary

Phase 4 trial update shows romosozumab for enhancing skeletal integrity in osteoporosis (including postmenopausal osteoporosis and osteoporotic fracture) is act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evenity (romosozumab)

Snippet

Sponsor: Susan L. Greenspan | Conditions: Osteoporosis, Osteoporosis, Postmenopausal | Phase 4 | Status: ACTIVE_NOT_RECRUITING